SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010182
Filing Date
2020-08-10
Accepted
2020-08-10 16:06:50
Documents
61
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q omer-20200630x10q.htm   iXBRL 10-Q 1157143
2 EX-10.1 omer-20200630xex10d1.htm EX-10.1 36549
3 EX-31.1 omer-20200630xex31d1.htm EX-31.1 11319
4 EX-31.2 omer-20200630xex31d2.htm EX-31.2 12506
5 EX-32.1 omer-20200630xex32d1.htm EX-32.1 8092
6 EX-32.2 omer-20200630xex32d2.htm EX-32.2 7638
7 GRAPHIC omer-20200630x10q005.jpg GRAPHIC 34771
  Complete submission text file 0001558370-20-010182.txt   5260232

Data Files

Seq Description Document Type Size
8 EX-101.SCH omer-20200630.xsd EX-101.SCH 29093
9 EX-101.CAL omer-20200630_cal.xml EX-101.CAL 46895
10 EX-101.DEF omer-20200630_def.xml EX-101.DEF 86731
11 EX-101.LAB omer-20200630_lab.xml EX-101.LAB 331721
12 EX-101.PRE omer-20200630_pre.xml EX-101.PRE 236930
13 EXTRACTED XBRL INSTANCE DOCUMENT omer-20200630x10q_htm.xml XML 1023765
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 201089383
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences